Patients with cirrhosis should be immunized against hepatitis A (HAV) & hepatitis B (HBV) as they are high risk for decompensation if infected. Baseline data at the Atlanta VA hepatology clinics demonstrated 75% of veterans with cirrhosis were immune to HAV and 44% to HBV. One fourth of visits failed to address hepatitis vaccines, and 60% of missed opportunities were from providers not discussing it. Our aim was to reduce missed opportunities to initiate HAV and HBV vaccination to <10% and to confirm immunity with serologies to <10% over 6 months in the Atlanta VA hepatology clinics.